Skip to main content
Healthcare

STAT+: Nonprofit resurrects shelved gene therapy after startup shuts down 

STAT+: Nonprofit resurrects shelved gene therapy after startup shuts down 

Feed excerpt — reported by STAT News

Last year, U.K. gene therapy startup Bloomsbury Genetic Therapies announced it was shutting down after dosing just one patient. Now, a nonprofit is resurrecting its lead program:

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →

Original Source

This article was syndicated from STAT News. All rights remain with the original publisher.